BNC Korea Co., Ltd. (256840.KQ)
KRW 4160.0
(-1.42%)
KRW 4160.0
(-1.42%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -67.65 Billion KRW | 32.54% |
| 2022 | -100.28 Billion KRW | -585.84% |
| 2021 | 20.64 Billion KRW | 19.76% |
| 2020 | 17.23 Billion KRW | 504.45% |
| 2019 | -4.26 Billion KRW | -999.6% |
| 2018 | 473.71 Million KRW | 104.08% |
| 2017 | -11.62 Billion KRW | 1.09% |
| 2016 | -11.75 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -69.1 Billion KRW | -11.89% |
| 2024 Q1 | -61.76 Billion KRW | 8.7% |
| 2023 Q1 | -93.98 Billion KRW | 6.28% |
| 2023 Q4 | -67.65 Billion KRW | 15.45% |
| 2023 Q3 | -80 Billion KRW | 0.41% |
| 2023 Q2 | -80.33 Billion KRW | 14.52% |
| 2023 FY | -67.65 Billion KRW | 32.54% |
| 2022 Q4 | -100.28 Billion KRW | 6.14% |
| 2022 Q2 | -120.82 Billion KRW | -6.28% |
| 2022 Q1 | -113.69 Billion KRW | -650.8% |
| 2022 Q3 | -106.84 Billion KRW | 11.57% |
| 2021 Q4 | 20.64 Billion KRW | -54.29% |
| 2021 Q3 | 45.15 Billion KRW | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 18.96 Billion KRW | 456.783% |
| CMG Pharmaceutical Co., Ltd. | 18.78 Billion KRW | 460.146% |
| Celltrion Pharm, Inc. | 142.81 Billion KRW | 147.369% |
| Huons Global Co., Ltd. | 13.26 Billion KRW | 609.996% |
| DongKook Pharmaceutical Co., Ltd. | 44.19 Billion KRW | 253.075% |
| Enzychem Lifesciences Corporation | -9.81 Billion KRW | -589.379% |
| Humedix Co., Ltd. | -77.54 Billion KRW | 12.76% |
| Boditech Med Inc. | -31.92 Billion KRW | -111.896% |
| EuBiologics Co., Ltd. | 4.88 Billion KRW | 1485.856% |
| FutureChem Co.,Ltd | -4.93 Billion KRW | -1272.048% |
| Huons Co., Ltd. | 73.9 Billion KRW | 191.531% |
| AptaBio Therapeutics Inc. | -12.08 Billion KRW | -459.916% |